Paula Alvarez

Oviedo, AS, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Uncovering heterogeneous health burden in axial spondyloarthritis through latent class analysis of the ASAS health index.

Uncovering heterogeneous health burden in axial spondyloarthritis through latent class analysis of the ASAS health index.

Journal: The Journal of rheumatology

Published: September 01, 2026

Waist circumference provides improved cardiometabolic discrimination compared with body mass index in psoriatic disease: discrimination and reclassification analyses.

Waist circumference provides improved cardiometabolic discrimination compared with body mass index in psoriatic disease: discrimination and reclassification analyses.

Journal: Postgraduate medicine

Published: August 30, 2026

Multisite Atherosclerosis and SCORE2-Based Risk Stratification in Psoriatic Arthritis: A Phenotype-Dependent Role of Vascular Territories.

Multisite Atherosclerosis and SCORE2-Based Risk Stratification in Psoriatic Arthritis: A Phenotype-Dependent Role of Vascular Territories.

Journal: Biomedicines

Published: May 09, 2026

Serum Urate as a Cardiometabolic Risk Enhancer Beyond SCORE2 in Psoriatic Arthritis.

Serum Urate as a Cardiometabolic Risk Enhancer Beyond SCORE2 in Psoriatic Arthritis.

Journal: Journal of clinical medicine

Published: April 03, 2026

Association between adiposity and psoriatic arthritis beyond classical clinical predictors.

Association between adiposity and psoriatic arthritis beyond classical clinical predictors.

Journal: Clinical rheumatology

Published: February 19, 2026

Comparative cost-utility analysis of ixekizumab, tofacitinib, and golimumab in psoriatic arthritis: a real-world Markov model simulation.

Comparative cost-utility analysis of ixekizumab, tofacitinib, and golimumab in psoriatic arthritis: a real-world Markov model simulation.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: February 09, 2026

Determinants of Structural Joint Damage in Psoriatic Arthritis: Limited Association with Disease Activity and Modest Link with Health Impact.

Determinants of Structural Joint Damage in Psoriatic Arthritis: Limited Association with Disease Activity and Modest Link with Health Impact.

Journal: Journal of clinical medicine

Published: January 14, 2026

Cardiometabolic Candidate Endotypes in Psoriatic Disease: Integration of Clinical, Metabolic, and Immunogenetic Data Across Psoriasis and Psoriatic Arthritis.

Cardiometabolic Candidate Endotypes in Psoriatic Disease: Integration of Clinical, Metabolic, and Immunogenetic Data Across Psoriasis and Psoriatic Arthritis.

Journal: Life (Basel, Switzerland)

Published: November 20, 2025

Golimumab retention in patients with psoriatic arthritis and axial spondyloarthritis: evidence from up to a decade of follow-up.

Golimumab retention in patients with psoriatic arthritis and axial spondyloarthritis: evidence from up to a decade of follow-up.

Journal: Expert review of clinical pharmacology

Published: May 17, 2025

Early axial spondyloarthritis versus established disease: a single-center analysis based on the new ASAS definition of early disease.

Early axial spondyloarthritis versus established disease: a single-center analysis based on the new ASAS definition of early disease.

Journal: Clinical rheumatology

Published: November 12, 2024

Psoriatic arthritis phenotype may vary depending on whether the skin or joint domain appears first or whether both appear simultaneously.

Psoriatic arthritis phenotype may vary depending on whether the skin or joint domain appears first or whether both appear simultaneously.

Journal: Clinical and experimental rheumatology

Published: November 09, 2024

C-reactive protein thresholds for discriminating active disease in psoriatic arthritis may be different in early versus established disease.

C-reactive protein thresholds for discriminating active disease in psoriatic arthritis may be different in early versus established disease.

Journal: Clinical and experimental rheumatology

Published: September 04, 2024

Showing 1-12 of 15

Last Updated: 09/26/2026